Atlas Trials

CM336 Plus Isa-VR in Newly Diagnosed Primary Plasma Cell Leukemia

Clinical trial NCT07652905 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07652905
Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Plasma Cell Leukemia (PCL)
Start date
2026-06-20
Primary completion
2029-06-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.